Lucid Diagnostics Inc (LUCD) Q3 2026 Earnings Call Highlights: Medicare Reimbursement ...
Lucid Diagnostics Inc (LUCD) sees Medicare claim-by-claim payments begin as October test volume hits a record 1,800, though Q3 revenue stayed flat at $1.2 million amid a pending MolDX LCD. Related Stocks: LUCD ,